Evidence map›Paper›PMID 36675705›Full record

ArticleJournal of personalized medicine2022

Macrophage-like Cells Are Increased in Retinal Vein Occlusion and Correlate with More Intravitreal Injections and Worse Visual Acuity Outcomes.

Sean M Rangwani, Stephen Hawn, Nathan C Sklar, Rukhsana G Mirza, Jeremy A Lavine

Open access · goldAbstract read
In one paragraph

Article in Journal of personalized medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 4 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Observational
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Sean M RangwaniDepartment of Ophthalmology, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA.
Stephen HawnDepartment of Ophthalmology, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA.
Nathan C SklarDepartment of Ophthalmology, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA.
Rukhsana G MirzaDepartment of Ophthalmology, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA.
Jeremy A LavineDepartment of Ophthalmology, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA.ORCID 0000-0002-0884-1336
Northwestern University · US

Funding

The role of beta2-adrenergic receptor and interleukin-6 signaling in macrophage-driven choroidal neovascularizationK08EY030923 · NEI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI LAVINE, JEREMY A · 2020 to 2024
$972k
NEI NIH HHS EY030923NEI NIH HHS K08 EY030923
6 · The paper itself

Abstract

Macrophage-like cells (MLCs) are an emerging retinal biomarker. MLCs are increased in retinal vein occlusion (RVO) eyes, but their predictive value is unknown. This study investigated if MLCs can predict meaningful clinical outcomes. This prospective, cross-sectional study involved 46 eyes from 23 patients with unilateral RVO. Patients' unaffected eyes were used as matched controls. MLCs were quantified to determine MLC density and percent image area. We collected demographic, clinical, ocular, and imaging characteristics at the time of MLC imaging. We additionally recorded best corrected visual acuity (BCVA) and number of intravitreal injections at 6 months and 12 months post-imaging. MLC density and percent area increased by 1.86 (

Indexed as

macrophage-like cell (MLC)maculaOCTAoptical coherence tomography angiographyretinaretinal vein occlusionRVO

Identifiers

PMID36675705
PMCPMC9860779
OpenAlexW4313260738

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.